We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+22.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$68.5B
AUM Growth
+$9.41B
Cap. Flow
-$1.48B
Cap. Flow %
-2.16%
Top 10 Hldgs %
11.5%
Holding
2,417
New
97
Increased
651
Reduced
820
Closed
64

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$694M
2
BNY
Bank of New York Mellon
BNY
+$668M
3
MRSH
Marsh
MRSH
+$609M
4
DIS icon
Walt Disney
DIS
+$140M
5
TFC icon
Truist Financial
TFC
+$128M

Sector Composition

Rank Sector Weight
1 Technology 18.62%
2 Healthcare 15.47%
3 Financials 13.03%
4 Industrials 11.38%
5 Consumer Discretionary 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEO icon
1576
NeoGenomics
NEO
$1.75B
$227K ﹤0.01%
4,219
PNR icon
1577
Pentair
PNR
$10.6B
$227K ﹤0.01%
4,285
-90,077
-95% -$4.62M
ENSG icon
1578
The Ensign Group
ENSG
$10.5B
$225K ﹤0.01%
3,099
SMC
1579
Summit Midstream
SMC
$412M
$225K ﹤0.01%
+18,002
New +$232K
MRCY icon
1580
Mercury Systems
MRCY
$6.02B
$222K ﹤0.01%
2,523
FLO icon
1581
Flowers Foods
FLO
$1.65B
$221K ﹤0.01%
9,777
LU icon
1582
Lufax Holding
LU
$1.38B
$219K ﹤0.01%
+3,864
New +$231K
MAT icon
1583
Mattel
MAT
$4.46B
$219K ﹤0.01%
12,575
MEDP icon
1584
Medpace
MEDP
$16.3B
$219K ﹤0.01%
1,575
AL
1585
DELISTED
Air Lease Corp
AL
$215K ﹤0.01%
4,836
GMED icon
1586
Globus Medical
GMED
$10.8B
$214K ﹤0.01%
3,286
NOV icon
1587
NOV
NOV
$7.23B
$213K ﹤0.01%
15,531
-2,104
-12% -$23.8K
FTDR icon
1588
Frontdoor
FTDR
$5.17B
$212K ﹤0.01%
4,213
RMBS icon
1589
Rambus
RMBS
$9.81B
$212K ﹤0.01%
12,129
TWOU
1590
DELISTED
2U Inc
TWOU
$212K ﹤0.01%
113
+37
+49% +$39.7K
PRGS icon
1591
Progress Software
PRGS
$1.66B
$211K ﹤0.01%
4,677
-582
-11% -$23.5K
SPSC icon
1592
SPS Commerce
SPSC
$2.51B
$210K ﹤0.01%
1,930
HBI
1593
DELISTED
Hanesbrands
HBI
$208K ﹤0.01%
14,253
-375,039
-96% -$5.66M
NDSN icon
1594
Nordson
NDSN
$16.8B
$208K ﹤0.01%
1,033
-23,949
-96% -$4.81M
P
1595
Everpure Inc
P
$24B
$207K ﹤0.01%
9,164
IT icon
1596
Gartner
IT
$10.5B
$206K ﹤0.01%
1,284
KRO icon
1597
KRONOS Worldwide
KRO
$723M
$206K ﹤0.01%
13,800
-42,300
-75% -$597K
BHVN
1598
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$206K ﹤0.01%
2,398
HXL icon
1599
Hexcel
HXL
$8.27B
$205K ﹤0.01%
4,237
NLSN
1600
DELISTED
Nielsen Holdings plc
NLSN
$205K ﹤0.01%
9,800
-5,879
-37% -$95.4K

Similar funds

Macquarie Group's Q4 2020 Portfolio in Review

As of Q4 2020, Macquarie Group held 2,417 positions worth $68.5B, up 16% from $59.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Macquarie Group's Q4 2020 filing shows 97 new, 651 increased, 820 reduced and 64 closed positions. Its largest new stake was iShares Core S&P Total US Stock Market ETF: 1,556,025 shares worth $134M. The largest sale was Pfizer, an estimated $694M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Macquarie Group's largest Q4 2020 buy was iShares Core S&P Total US Stock Market ETF: 1,556,025 shares worth $134M.
  • Macquarie Group added most to Discover Financial Services in Q4 2020, an estimated $613M increase.
  • Macquarie Group's biggest Q4 2020 reduction was Pfizer, cutting an estimated $694M.
  • Macquarie Group fully exited MyoKardia, Inc. Common Stock in Q4 2020, selling an estimated $64.8M.
  • Macquarie Group's ten largest holdings make up 11% of its $68.5B portfolio in Q4 2020.
  • Macquarie Group opened 97 new positions and closed 64 in Q4 2020.
  • Macquarie Group's portfolio value rose 16% quarter-over-quarter to $68.5B.

Based on Macquarie Group's 13F filing for Q4 2020, filed 16 Feb 2021.